Email this article EFFICIENCY OF HORMONE THERAPY WITH LEIPRORELIN (LUCRIN DEPOT®) IN PATIENTS WITH PROSTATE CANCER
- Authors: Alekseev B.Y.1, Kaprin A.D.2, Nyushko K.M.3
-
Affiliations:
- Department of Oncourology, P.A. Herzen Moscow Oncology Research Institute Department of Urology with a Course of Oncourology, Faculty for Postgraduate Training of Medical Workers, Russian Peoples Friendship University
- Department of Urology with a Course of Oncourology, Faculty for Postgraduate Training of Medical Workers, Russian Peoples Friendship University City Clinical Hospital Twenty, Moscow
- Department of Oncourology, P.A. Herzen Moscow Oncology Research Institute
- Issue: Vol 7, No 1 (2011)
- Pages: 57-61
- Section: PROSTATE CANCER
- Published: 30.03.2011
- URL: https://oncourology.abvpress.ru/oncur/article/view/100
- DOI: https://doi.org/10.17650/1726-9776-2011-7-1-57-61
- ID: 100
Cite item
Full Text
Abstract
Prostate cancer (PC) is one of the most common cancers. Hormone therapy (HT) is the basic treatment for metastatic hormone-sensitive PC. HT with luteinizing-hormone-releasing hormone (LHRH) analogues is considered to be an effective method for hormone exposure as monotherapy and in combination with other drugs. Lucrin depot® is a potent and safe LHRH analogue whose efficacy has been proven by a number of clinical trials. This drug may be recommended as monotherapy or in combination with other hormonal agents in patients with PC if there are indications for androgen deprivation.
About the authors
B. Ya. Alekseev
Department of Oncourology, P.A. Herzen Moscow Oncology Research InstituteDepartment of Urology with a Course of Oncourology,
Faculty for Postgraduate Training of Medical Workers, Russian Peoples Friendship University
Author for correspondence.
Email: byalekseev@mail.ru
Кафедра урологии с курсом онкоурологии Russian Federation
A. D. Kaprin
Department of Urology with a Course of Oncourology,Faculty for Postgraduate Training of Medical Workers, Russian Peoples Friendship University
City Clinical Hospital Twenty, Moscow
Email: byalekseev@mail.ru
Russian Federation
K. M. Nyushko
Department of Oncourology, P.A. Herzen Moscow Oncology Research Institute
Email: byalekseev@mail.ru
Russian Federation
References
Supplementary files
